ProCE Banner Activity

Consensus and Disagreement Among Experts in Treatment of Patients With HER2+ Early-Stage Breast Cancer Suggests an Unmet Need for an Online Decision Support Tool


Treatment options for HER2+ EBC are continuing to evolve, increasing the complexity of treatment decision making. As treatment options expand, so does the need for online decision aids. The aim of this analysis was to assess real-world global practice patterns for HER2+ EBC and compare them with recommendations from US experts based on patient cases entered by healthcare providers into an online decision support tool designed to provide specific, patient-individualized expert recommendations.

Released: December 03, 2018

Expiration: December 02, 2019

No longer available for credit.


Additional Information

Tradd Sanderson
Director of Marketing
Clinical Care Options
Telephone: 855.224.2241